LIPOATROPHIC DIABETES. II. METABOLIC STUDIES CONCERNING THE MECHANISM OF LIPEMIA.
D000305:Adrenal Cortex Hormones; D000324:Adrenocorticotropic Hormone; D002784:Cholesterol / Q000097:blood*; D003923:Diabetes Mellitus, Lipoatrophic; D003922:Diabetes Mellitus, Type 1; D004041:Dietary Fats; D005227:Fatty Acids; D005989:Glycerides; D006801:Humans; D006949:Hyperlipidemias; D007223:Infant; D007328:Insulin; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood*; D008060:Lipodystrophy; D008071:Lipoprotein Lipase; D008797:Metyrapone; D000451:Mineralocorticoid Receptor Antagonists; D010600:Pharmacology; D010743:Phospholipids
D000305:Adrenal Cortex Hormones; D004041:Dietary Fats; D005227:Fatty Acids; D005989:Glycerides; D007328:Insulin; D008055:Lipids; D000451:Mineralocorticoid Receptor Antagonists; D010743:Phospholipids; D000324:Adrenocorticotropic Hormone; D002784:Cholesterol; D008071:Lipoprotein Lipase; D008797:Metyrapone
ADRENAL CORTEX HORMONES; ALDOSTERONE ANTAGONISTS; BLOOD CHOLESTEROL; BLOOD LIPIDS; CORTICOTROPIN; DIABETES MELLITUS, JUVENILE; FAT TOLERANCE TEST; FATTY ACIDS; GLYCERIDES; HYPERLIPEMIA; INFANT; INSULIN; LIPID METABOLISM; LIPODYSTROPHY; LIPOPROTEIN LIPASE; METYRAPONE; PHARMACOLOGY; PHOSPHOLIPIDS